EFFECTS OF TENIDAP ON LEUKOCYTE-ENDOTHELIAL CELL-ADHESION IN MESENTERIC VENULES

Citation
J. Panes et al., EFFECTS OF TENIDAP ON LEUKOCYTE-ENDOTHELIAL CELL-ADHESION IN MESENTERIC VENULES, Journal of rheumatology, 22(3), 1995, pp. 444-449
Citations number
33
Categorie Soggetti
Rheumatology
Journal title
ISSN journal
0315162X
Volume
22
Issue
3
Year of publication
1995
Pages
444 - 449
Database
ISI
SICI code
0315-162X(1995)22:3<444:EOTOLC>2.0.ZU;2-Z
Abstract
Objective, To compare the proinflammatory effects of tenidap to those of indomethacin, and to assess the influence of lipoxygenase inhibitio n with either a leukotriene synthesis inhibitor (L663,536) or tenidap on platelet activating factor (PAF) induced leukocyte adhesion. Method s. Adherent leukocytes, emigrated leukocytes, number of rolling leukoc ytes/100 mu m venule, flux of rolling leukocytes, and leukocyte rollin g velocity were quantitated in mesenteric venules (25-35 mu m diameter and > 150 mu m length) of Sprague-Dawley rats using intravital micros copy. In,some experiments, the mesentery was superfused with indometha cin (25 mu g/ml), tenidap (30 mu g/ml), or both drugs simultaneously. In other experiments the mesentery was superfused with PAF 100 nM and the effects of treatment with 1,663,536 (Ip mg/kg given orally) or sup erfusion with tenidap were determined. Results, Indomethacin significa ntly increased leukocyte rolling and adhesion. Tenidap did not promote leukocyte-endothelial cell adhesion and blocked the increased leukocy te rolling and adhesion promoted by indomethacin. Both L663,536 and te nidap significantly attenuated PAF induced leukocyte-endothelial cell adhesion. Conclusion, Tenidap does not exhibit the proinflammatory pro perties of indomethacin. The reduction of indomethacin or PAF induced leukocyte-endothelial :cell adhesion by tenidap appeared to result fro m its lipoxygenase inhibitory activity. Modulation of leukocyte-endoth elial cell adhesion may be a never mechanism of the antiinflammatory a ctivity of tenidap and may reduce the relative risk of gastric ulcerat ion with tenidap.